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A b s t r a c t -  Sophisticated methods available to quantitate hormone secretion and 
hormone action provide opportunities to identify potential endocrine biomarkers of 
aging. However,  there are many challenges facing the investigator who wishes to 
establish an endocrine biomarker. Circulating levels of  many hormones fluctuate on a 
circadian rhythm, and a variety of  other short-term fluctuations may occur. Hormone 
secretion is generally tightly regulated and often affected by multiple, redundant 
feedback mechanisms. Interpretation of circulating hormone levels must also take 
into account factors affecting hormone metabolism and degradation which may be 
influenced by age. The rate of  hormone secretion and circulating hormone levels are 
related to the sensitivity to hormone action by feedback control mechanisms. Thus 
interpretation of  potential circulating endocrine markers of  aging must take into 
account changes in sensitivity to that hormone as well. 
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INTRODUCTION 
THE ENDOCRINE system is concerned with the secretion of hormones, or chemical 
messengers, into the circulatory system and the subsequent action of these messengers 
at distant sites to regulate a number of internal homeostatic control mechanisms. Thus, 
aspects of the endocrine systems' function can be assessed by direct measurements of 
hormone levels in the circulatory system. With the development of sophisticated 
methods for accurate measurement of circulating hormone levels, there has been con- 
siderable opportunity to obtain such measurements in humans and a variety of animal 
species to determine whether hormone levels change with aging. Such measurements 
have provided the basis for proposing a number of endocrine hormones or neurotrans- 
mitters as biomarkers of aging. However, a number of factors must be considered in the 
interpretation of circulating hormone levels and their potential use as biomarkers for 
aging. 
Studies of circulating hormones must take into account the fact that most hormones 
do not circulate at constant levels, but fluctuate considerably. The circulating hormone 
level is also a function of a dynamic equilibrium between rates of hormone secretion 
and hormone metabolism. Thus, a change in hormone level with age can reflect not only 
a change in the rate of hormone secretion, but also a change in the rate at which the 
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FIG. 1. Compar i son  o f  se rum tes tos terone  levels over  a 24-h period in heal thy young  (n = 17) 
and old (n = 12) men.  Note the diurnal rhy thm of  se rum tes tos terone  that is apparent  in the 
young.  The diurnal  rhy thm is blunted in the  elderly. Thus ,  there are significant age differ- 
ences  at night  and in the morning  (asterisks),  but  little age difference at midday (from 
Bremner  et al., Loss  of  circadian rhythmici ty  in blood tes tos terone levels with aging in 
normal  men.  J. Clin. Endocrinol. Metab.,  56, 1278-1281, © The Endocr ine  Society 1983. 
hormone is metabolized. Hormone secretion is tightly regulated, often by many differ- 
ent factors. Because hormones mediate control of internal homeostasis, they are par- 
ticularly likely to change in response to environmental factors or stimuli. Thus, any 
apparent change in hormone levels with aging must take into account possible interac- 
tions between age and a variety of environmental factors. Finally, most hormones are 
regulated in the context of a feedback control system that provides for a close interac- 
tion between hormone secretion and hormone action. Thus, if resistance to hormone 
action develops, there is generally a feedback response to enhance hormone secretion. 
This article will present some examples of how each of these aspects of endocrine 
system function may influence the interpretation of potential biomarkers of aging. 
FLUCTUATIONS OF HORMONE LEVELS 
There are several different types of fluctuations of hormone levels that are recog- 
nized. The most widely known type of fluctuation is related to the circadian cycle. 
While it is widely recognized that hormones such as cortisol exhibit considerable cir- 
cadian variation, circadian variation of other hormones also occurs and may affect 
interpretation of data. For example, there has been considerable controversy about 
whether circulating levels of testosterone decline in elderly men, based on studies 
which have relied on single measurements made during the day (Harman and Tsitouras, 
1980; Sparrow e t  al . ,  1980; Zumoffet  al. ,  1982; Davidson e t  al . ,  1983; Desylpere and 
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Vermeulen, 1984). However, as illustrated in Figure 1, there is a diurnal rhythm of 
serum testosterone. The largest age-related difference occurs at night when testos- 
terone levels are highest in the young. It is apparent that measurements made during 
midday are most likely to miss the age-related fall in testosterone levels (Bremner et al., 
1983). If a decline of testosterone levels is to be used as a marker of an age-related 
change in testicular function, the timing and frequency of such measurements need to 
be seriously considered. Similarly, growth hormone levels are considerably lower in the 
elderly than in the young, but this difference cannot be detected if measurements are 
made only during the day. In young adults, growth hormone secretion occurs at night in 
association with deep slow wave sleep. It is this aspect of growth hormone secretion 
that is specifically diminished in the elderly (Prinz et  al., 1983). 
In addition to the diurnal swings of hormone levels that must be taken into account in 
interpreting aging studies, there are short-term fluctuations in hormone levels which 
can interfere with interpretation of results. For example, it is clear that gonadotropins 
are secreted in a pulsatile manner, reflecting responses to pulsatile secretion of hypo- 
thalamic peptides (Casper et  al., 1979; Coquelin and Desjardins, 1982). As a result, 
interpretation of a single measurement of luteinizing hormone, for example, is very 
difficult. Characterization of the frequency and magnitude of pulsatile luteinizing hor- 
mone secretion is essential for adequate assessment of the integrity of this system. 
Alterations in the pattern of secretion could potentially provide a sensitive biomarker of 
aging of the neuroendocrine system. 
REGULATION OF HORMONE SECRETION 
Most hormones are part of a feedback control mechanism in which there is a single 
primary signal that regulates hormone secretion. However in addition to this primary 
signal, there are often multiple other signals which may also interact to determine the 
rate of hormone secretion. For example, the circulating glucose level is the most impor- 
tant regulator of insulin secretion. However there are multiple other hormones, neuro- 
transmitters, and metabolites which can interact with glucose to enhance or inhibit 
glucose mediated insulin secretion. Thus, for interpretation of circulating insulin levels 
as a potential biomarker of aging, one would have to control not only for the circulating 
glucose level, but the whole host of other factors which can also interact. Similarly, 
secretion of thyroid hormone is controlled primarily by pituitary release of thyroid 
stimulating hormone that in turn is primarily controlled by hypothalamic secretion of 
thyrotropin releasing hormone. It is clear that a number of other neuroendocrine and 
nutritional factors can interact with this system at multiple levels which can influence 
hormone output. A number of early studies of plasma T3 levels reported an age-related 
decline in humans. However, it was subsequently learned that regulation of thyroid 
hormone secretion can be greatly influenced by stressful illness and poor nutrition. 
When subsequent studies were done excluding elderly people who were sick or mal- 
nourished, no age-related decline in T3 levels could be documented (Olsen et al., 1978). 
CIRCULATING HORMONE KINETICS 
Since a number of hormones are removed rapidly from the circulation, alterations in 
removal mechanisms can have a considerable effect on the circulating hormone level. A 
number of approaches are available to assess the kinetics of hormone secretion and 
removal. One approach is to infuse the hormone of interest and estimate the hormone 
clearance rate as the infusion rate divided by the difference between the hormone level 
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achieved and the basal hormone level. Because infusion of a hormone may cause 
physiologic effects which may influence the hormones clearance rate, a better approach 
is to infuse tracer amounts of radiolabelled hormone to assess its distribution and 
metabolism. One example of an age-related change in hormone kinetics is the observa- 
tion from several laboratories that the clearance rate of insulin is diminished in healthy 
elderly people (Minaker et  al. ,  1982; Reaven et al., 1982; Fink et al., 1985). Thus, 
plasma insulin levels in the elderly will tend to be an overestimate of acutal insulin 
secretion. The clearance rate of the neurotransmitter norepinephrine from the circula- 
tion also tends to be diminished in the elderly, but tracer kinetic studies have indicated 
that the age-related increase in plasma norepinephrine is primarily due to an increased 
rate of norepinephrine spillover into the circulation (Veith et  al., 1986). 
INTERACTION OF HORMONE SECRETION AND HORMONE ACTION 
Sophisticated approaches to quantitative estimation of hormone action have been 
developed in recent years and have provided evidence for an age-related decline in 
hormone responsiveness in a number of systems. Hormone action at the cellular level 
initially involves interaction with a specific hormone receptor. As a result of this in- 
teraction a signal is generated which activates mechanisms that ultimately lead to the 
cellular response. In the case of peptide hormones and the catecholamines, which do 
not readily penetrate cell membranes, the receptor is located on the cell surface. The 
hormone receptor interaction results in activation of one or more intracellular protein 
kinases that phosphorylate enzymes which initiate a cascade of events resulting in the 
cellular response. In the case of steroid hormones, which penetrate cell membranes 
readily, the receptors are located intracellularly and mediate transfer of the steroid 
hormone to the nucleus of the cell where the hormone acts to regulate cellular protein 
synthesis by affecting the translation of DNA. Thus, it is apparent that alterations of 
hormone action in aging may involve any of these complex processes. Since hormone 
binding to specific receptors can be measured most readily, many studies of aging have 
involved such measurements. However, as more is being learned about the mediators 
resulting from the hormone receptor interaction, more work has focused on this aspect 
of hormone action. 
In general, measurements of hormone binding to specific receptors have not shown 
consistent defects in aging even though tissue responsiveness to many hormones is 
diminished. Examples include reduced responsiveness to beta adrenergic stimulation in 
aging in the absence of consistent changes of beta adrenergic receptor number (Hein- 
simer and Lefkowitz, 1985) and a decline in sensitivity to the effects of insulin on 
glucose metabolism in the absence of a consistent change of insulin receptor number 
(Fink et  al. ,  1983; Rowe et  al., 1983). 
An important adjunct to measurement of hormone receptors is the assessment of the 
cellular response to the hormone. An example is the assessment of hormone mediated 
regulation of the enzyme adenylcyclase by measurement of the production of cyclic 
AMP by the cell. An age-related impairment of production of cyclic AMP in response to 
beta adrenergic stimulation has been demonstrated in a number of tissues both in experi- 
mental animals and humans (Heinsimer and Lefkowitz, 1985). As illustrated in Fig. 2, 
there is an analogous impairment of inhibition of cyclic AMP production by platelet 
membranes in response to alpha adrenergic receptor stimulation with epinephrine in 
elderly compared to young humans (Supiano et  al . ,  1987). 
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FIG. 2. Dose--response relationship for adenylate cyclase activity. The dose-response rela- 
tionship in elderly and young subject groups for epinephrine (EPI) mediated inhibition of 
cAMP production (range 10 -8 to 10 -4 M) expressed as a percentage (mean ± SEM) of 
maximal sodium fluoride stimulated activity (%AC INH). There is a significant age effect by 
ANOVA (19 < 0.02) (from Supiano et al., Function uncoupling of the platelet alpha~z- 
adrenergic receptor-adenylate cyclase complex in the elderly, J. Clin. Endocrinol. Metab.,  
64, 1160-I 164, © The Endocrine Society 1987. 
The relationship be tween  altered cellular respons iveness  to hormones  and the cir- 
culating hormone  level also needs to be considered.  When circulating levels of  the 
hormone  are elevated,  this could represent  an appropr ia te  response  to resistance to the 
act ion of  the hormone.  Alternat ively,  if there is a pr imary  mechan ism resulting in 
increased circulating hormone  levels, changes in recep tor  function may  occur  which are 
secondary.  Studies of  a number  of  h o r m o n e - r e c e p t o r  sys tems have indicated that  in- 
creased hormone  levels result  in downregulat ion of  hormone  responsiveness .  The ad- 
renergic sys tem is a good example  of  this phenomenon .  The increased circulating levels 
of  norepinephrine  obse rved  in many  studies in the elderly could represent  an appropri-  
ate response  to impaired cellular respons iveness  to ca techolamines  (Linares and Hal-  
ter,  1987). Alternat ively,  diminished adrenergic sensitivity in the elderly could repre-  
sent an appropr ia te  downregulat ion response  to chronic elevat ion of  ca techolamine 
levels. 
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SUMMARY 
Sophisticated methods available to quantitate hormone secretion and hormone action 
provide a number of  opportunities to identify potential endocrine biomarkers of  aging. 
However, there are many challenges facing the investigator who wishes to establish an 
endocrine biomarker. By their very nature, endocrine systems are tightly regulated and 
often affected by multiple, redundant feedback mechanisms. Thus, careful control of 
such other factors must be considered when trying to tightly link a specific change in the 
endocrine system to the aging process. Both hormone secretion and hormone action 
appear to be so regulated. Thus, both of  these aspects of  endocrine system regulation need 
to be studied in order to interpret the meaning of hormone measurements and their 
potential relationship to aging. 
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